The key to a successful partnership is a true understanding of your partner needs from top to bottom and delivering knowledge and a solution that “lives” within the organization for many years. While many consultants use only an expert approach for strategic guidance and business process improvement (BPI), MOMENTUM has found it does not foster the team building, consensus, or ownership required to make BPI projects successful.
MOMENTUM’s approach is a unique blend of the expert and advisory consulting approaches. The advisory approach fosters a coach/mentor relationship between the consultant and the client. Our clients are actively involved in each phase of the project and participate in every step along the way. This creates synergy and encourages team building. Ideally we like to get a general overview of the process and then map the process with the users to review it from their perspective. It ensures that you capture how the process really works or should work. The interaction helps gain consensus and promotes ownership of business problems and solutions.
We share knowledge and practical experiences that lead to implementable business solutions. This approach advises and guides clients in a positive direction so they discover and own the solution.
Principal of MOMENTUM Consulting, Ms. Palmieri possesses extensive experience and expertise in all aspects of the laboratory services industry. Ms. Palmieri has spent close to 30 years in diagnostics and specifically the anatomic pathology laboratory industries, serving in numerous leadership positions for sales, operations, and executive capacities for both laboratory service and consulting organizations. Recently she served as President of DiagnoCure US, where she was responsible for sales, marketing, quality assurance and overall operations. During her tenure, she developed a new business model and facilitated the sale of the US asset.
Prior to this position, Ms. Palmieri served as the VP and Senior VP of Operations for Laboratory Corporation of America/DIANON Systems. Here she managed 6 locations, and $300M in business. She was a founding member of the leadership team that grew DIANON into a successful $200M national laboratory services company, which was sold to Laboratory Corporation of America for $600M in 2003.
Ms. Palmieri possesses expertise in both executive and operational management. Her skills include strategic business planning, commercialization of products, mergers and acquisitions, productivity, developing and maintaining client-focused partnerships, customer retention, supply chain management/logistics, and hands-on management.
Ms. Palmieri received her BS degree in Medical Technology from Western Connecticut State University and currently resides in Connecticut with her family.
A consultant with MOMENTUM, Ms. Manshadi has extensive experience in operational and quality assurance aspects of anatomic and molecular diagnostic laboratories With thirty years of experience in Laboratory Operations, Quality Management Systems, (ISO 9001, ISO 15189) Regulatory Affairs (State, CLIA, CAP, FDA), and Process improvement (Six Sigma, Lean) she Collaborates with clients to provide practical, effective, efficient and compliant processes to Achieve Product and Service Excellence.
Mojgan Manshadi is board certified by the American Society of Clinical Pathology (ASCP), the California Clinical Laboratory Scientist (CLS) and is a Six Sigma Trained Black Belt.
She gained her reference Laboratory experience starting at Nichols Institute and Quest Diagnostics laboratories where she played a critical role establishing Nichols Coagulation laboratory, implementing their Quality Management System, ISO 9001 Certifications and completing major Six Sigma projects. In 2003 she joined US LABs in Irvine, California as the Director of Quality and Regulatory Affairs. After the acquisition of US LABS by Laboratory Corporation of America, she served as the Vice President of Quality for the Esoteric Business Division where she standardized a universal Quality Management System throughout the Division. Her most recent positions were Vice President/General Manager of USLABS, Vice President of Quality and Business Alignment of the Oncology Division of Laboratory Corporation of America.
Ms. Manshadi received her B.A. in Biology and Chemistry from California State University and she resides in California with her family.
A consultant with MOMENTUM, Ms. Miller has over sixteen years experience in the diagnostics and anatomic pathology laboratory industries, serving in numerous leadership positions for sales, operations, and executive capacities for laboratory service and capital equipment organizations. She began her sales leadership career at Ventana Medical Systems, Inc., and continued in senior sales leadership capacities at US Labs and DIANON Systems, both divisions of LabCorp. Ms. Miller served as General Manager and Director of Sales while at DIANON Systems, and General Manager and Senior Vice President of Pathology Solutions with PLUS Diagnostics. Ms. Miller served as the President – Pathology Service Division, Global Sales & Marketing for Laboratory and Urology Divisions for HealthTronics. Prior to entering diagnostics, Ms. Miller served in the U.S. Army, where she achieved the rank of Captain – Military Intelligence. Ms. Miller currently resides in Lafayette, Louisiana with her family.
A consultant with MOMENTUM, Dr. Owens is a senior healthcare executive with extensive management experience leading clinical and surgical pathology reference laboratories, including clinical trial studies. Dr. Owens has a broad scientific background in anatomic and hematopathology, immunology, infectious disease, molecular oncology, and genetics and has held COO and SVP positions at national reference laboratories, including Knight Diagnostic Laboratories at Oregon Health & Science University, Caris Life Sciences, Genzyme Genetics/ IMPATH and Nichols Institute.
Her responsibilities included managing operating budgets up to $50MM, extensive experience in CLIA/CAP laboratory operations in startup, turnaround, and translational growth, business strategy development and implementation, operational efficiencies across multiple locations, management team development and successor planning. Her expertise spans startups, M&A and strategic planning.
Dr. Owens received her Ph.D in Medical Microbiology and Immunology (emphasis Tumor Immunology) at UCLA, her M.B.A.in Management and Strategy at Pepperdine University, and B.S., M.S in Microbiology (emphasis Microbial Genetics) at Long Beach State University. She resides in Oregon with her family.
A consultant with MOMENTUM Consulting, Ms. Steier has extensive background in raising capital and advising on Mergers & Acquisition transactions and licensing and strategic partnerships. Ms. Steier has over 20 years of Investment Banking and Capital Markets experience, with a focus on the healthcare industry.
Most recently, Ms. Steier was a Managing Director in the Healthcare Investment Banking group at Morgan Joseph TriArtisan where she focused on the Diagnostics, Genomics and Personalized Medicine sectors. Prior to that, Ms. Steier was with Emerging Growth Equities, a boutique Investment Banking firm located in Philadelphia, PA. Throughout her career, Ms. Steier has worked with both start-up, small-cap and mid-cap companies.
Ms. Steier graduated from Emory University with a BA in Economics and attended The London School of Economics studying International Finance.
A consultant with MOMENTUM, Mr. Stephens has over twenty plus years in this field of Histology. Mr. Stephens has been an early adopter of strategies that capitalize on emerging pathology markets. A Six Sigma Green Belt he works at the intersection of business strategy, patient safety, process improvement and employee advocacy. He regularly advises major healthcare institutions on improvement opportunities using Lean/Six sigma. He is a frequent speaker at state and national histotechnology symposia and has two patents pending in informatics pathology.
Mr. Stephens currently resides in Arizona as well as Texas.
Matt is a seasoned healthcare executive with 29 years’ experience in the field of clinical diagnostics. For the past 13 years he has specialized in moving novel cytogenetic and molecular diagnostic technologies from early-stage development to full scale commercialization. His areas of expertise include identifying key target markets, defining product performance specifications, working closely with regulatory agencies (USFDA, etc.) to design and conduct efficient and effective clinical trials, devising effective billing & reimbursement strategies, and commercially deploying high-performance clinical assays in a cost-effective manner. He also has extensive experience recruiting and hiring highly experienced clinical sales experts and training them to drive rapid market penetration and revenue growth.
Prior to joining Momentum Consulting Matt was founder and CEO of PathCentral, a national provider of integrated pathology business solutions, which included a cloud-based laboratory information system (LIS) and esoteric cancer diagnostic testing services with a focus on novel genomic technologies, including array comparative genomic hybridization (aCGH) and next- generation DNA sequencing. Before that he was CEO of Pathology Business Services, a pathology billing company based in Torrance, CA, while at the same time serving as Group Administrator for Affiliated Pathologists Medical Group, a 45-person pathology group practice, also based in Torrance. Other roles have included founder and CEO of Combimatrix Molecular Diagnostics, Vice President of Operations for US LABS (now Labcorp), Director of Business Development for ChromaVision Medical Systems (now GE/Clarient), and Director of Laboratory Support Services for both Specialty Laboratories (now Quest Diagnostics) and Nichols Institute (now Quest Diagnostics). Matt received a B.A. in Biology from Eastern Connecticut State University and an M.B.A. from the University of Hartford.